PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS
PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS
저자
Yu, K. S.; Kim, B.; Shin, D.; Park, M. K.; Hwang, J. G.; Kim, M.; Chung, H.; Ghim, J.; Chung, J. Y.; Smolen, J. S.; Burmester, G. R.; Kim, S. H.; Bae, Y.; Jeon, D.; Yang, G.; Yoo, J.; Bae, J.; Keystone, E.